Elan chief Kelly Martin to leave
Friday 04 June 2010
Kelly Martin will step down from his post as chief executive of Elan Corporation in 2012 and leave the Irish drugs manufactuer in 2013, the company said yesterday.
Elan said it had changed Mr Martin's contract from "an open-ended agreement to a fixed-term agreement" which will see the former Merrill Lynch executive, who was hired in 2003, vacate the chief executive's chair in May 2012, and then continue as an executive adviser to the board until the end of January 2013.
Mr Martin's tenure has been marked by tensions about spending levels and his handling of the development of Tysabri, a treatment for multiple sclerosis, and the Alzheimer's drug Bapineuzumab.
Jennifer Lawrence attacks mass media again over body image
Jennifer Lawrence: 'It should be illegal to call someone fat on TV'
Ian Watkins: Police probed over earlier allegations as paedophile Lostprophets singer sentenced to 35 years for child sex offences
Iain Duncan Smith leaves Commons food banks debate early
DNA from a 50,000 year old toe shows Neanderthals were highly inbred
Devyani Khobragade: India-US row escalates over arrest of diplomat in New York
- 1 America's 'virgin births'? One in 200 mothers 'became pregnant without having sex'
- 2 Sun will 'flip upside down' within weeks, says Nasa
- 3 Christmas comes early: Justin Bieber is 'retiring from music'
- 4 Iain Duncan Smith leaves Commons food banks debate early
- 5 Children evacuated from swimming pool after prosthetic leg mistaken for paedophile
- < Previous
- Next >
iJobs Money & Business
£500 - £550 per day: Cornwallis Elt : Business Analyst Target Operating Mod...
£500 - £680 per day: Harrington Starr: Murex Business Analyst - 1000 CHF per d...
£60000 - £75000 per annum + Bonus and Benefits: Harrington Starr: A leading au...
£25000 - £32000 per annum: Harrington Starr: Junior Business Analyst - Banking...